Lebanon, New Hampshire – January 13, 2020 – Avitide Inc., the industry leader in the discovery and development of custom affinity purification resins, announce a partnership expansion with Allergan. Under the terms of the agreement, Avitide will use its proprietary affinity chromatography discovery, development, and supply platform for programs defined by Allergan.
“The expansion of our partnership with Allergan is built upon the technical success from a previous partnership. We look forward to continuing our work with Allergan in delivering custom affinity chromatography technologies that improve manufacturing processes for critical medicines,” said Kevin Isett, Avitide’s Chief Executive Officer.